🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the Pharmacokinetics of Danoprevir...
Status
Completed
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT03019991
Treatments Being Tested
The purpose of this study is to investigate the efficacy of orally administ...
Status
Completed
Location
Karolinska Institutet
Start Date
2023-05-01
Trial ID
NCT05823896
Treatments Being Tested
This three-part study will evaluate the pharmacokinetics and bioavailabilit...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01654211
Treatments Being Tested
The AGILE platform master protocol allows incorporation of a range of ident...
Status
Recruiting
Location
Desmond Tutu Health Foundation
Start Date
2020-07-03
Trial ID
NCT04746183
This study was designed to test the safety and effectiveness of EPZICOM(aba...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-07
Trial ID
NCT00244712
Treatments Being Tested
The purpose of this study is to determine the pharmacokinetic and safety pr...
Status
Completed
Location
Site Reference ID/Investigator# 15981
Start Date
2009-02
Trial ID
NCT00850044
Treatments Being Tested
The objective of this study is to evaluate the safety and efficacy of a reg...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2010-04
Trial ID
NCT01108510
Treatments Being Tested
GSK2838232 is a novel human immune virus (HIV) maturation inhibitor being d...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-02-18
Trial ID
NCT01802918
Treatments Being Tested
The goal of this clinical trial is to compare treatment with oral Paxlovid ...
Status
Active Not Recruiting
Location
Haukeland University Hospital
Start Date
2023-05-12
Trial ID
NCT05852873
Treatments Being Tested
This Phase Ⅱ/Ⅲ study is to evaluate whether or not there is a difference in...
Status
Completed
Location
Hefei First People's Hospital
Start Date
2022-08-19
Trial ID
NCT05506176